The
Renaissance
Series
Striving for TRANSFORMATIONAL VALUE:
Are we ready for radical change?
12th March: PARIS
Goal & Purpose
Why attend?
Register to attend
Programme
What is the Renaissance Series?
Goal & Purpose
We have reached an inflexion point, where the extraordinary advances in science-led pioneering treatments and the capabilities of digital technologies are promising to radically transform healthcare.
In this invitation only meeting, designed for Senior Pharmaceutical Executives across disciplines, Adelphi invites you to engage in thought-leading debate on the role of the pharmaceutical industry in embracing the radical changes required in the quest for Transformational Value.
Why Attend?
Speakers
Stuart Cooper
CEO Adelphi Meeting Chair
Indranil Bagchi
SVP Global Value and Access, Novartis (Kymriah, CAR-T)
Inka Heikkinen
Head of Scientific Content Development, EMEA at DIA
John New
COO NorthWest E-Health; Physician and Professor Salford Royal foundation Trust
Mads Lennox Hvenekilde
Lifecycle leader, Global Product Strategy, F. Hoffmann-La Roche
VP International Medical Affairs (TBA)
- A unique opportunity to spend a day in closed meeting discussion of the most disruptive driver of change in healthcare today.
- Hear the views of expert speakers from a physician, payer, patient and pharma perspective, all actively involved in addressing the transformation facing healthcare.
- Reflect on your own company strategy through informed discussion with the faculty and like-minded senior influencers from leading pharma companies.
Programme Summary
A New Tomorrow: keynote address – Stuart Cooper, CEO Adelphi Group, meeting chair
Calculating and demonstrating value of transformative therapies – Indranil Bagchi, SVP Global Value and Access at Novartis (Kymriah, CAR-T)
Frameworks to fit a changing landscape – Inka Heikkinen, Head of Scientific Content Development, EMEA at DIA
Digital and AI: creating and measuring holistic value to patients and society – John New, COO NorthWest E-Health; Physician and Professor Salford Royal foundation Trust
Agility: Leading the way with pioneering organizational transformation – Mads Lennox Hvenekilde Lifecycle leader, Global Product Strategy, F. Hoffmann-La Roche
Pivotal role for Medical Affairs – VP International Medical Affairs (TBA)
What is the Renaissance Series?
Adelphi’s Renaissance events have, over the years, become established as unique, one day invitation-only forums, at which senior Pharma leaders have the opportunity for discussion of the most dynamic drivers of major and disruptive change in Pharma in an intimate setting.
One Day Thought Leadership Forums based on issues that are driving major change in our industry, most recent forums have addressed:
Striving for Transformational Value 2018-2019
Patientcentricity: Defining our role 2016-2017
Real World Evidence: the new standard of proof? 2014-2015
Personalised Medicine: Moving from promise to practice 2012-2013
Each Adelphi Renaissance forum has its own unique expert faculty, who are passionate about the topic, representing a range of perspectives from academia, the medical profession, pharma industry, patients, regulatory and payer bodies.
The
Renaissance
Series
Expert exchange on disruptive drivers in healthcare.
Providing Adelphi’s key clients with a unique opportunity to debate the most disruptive drivers of change in our industry with US and European senior thought leaders in healthcare.
PURPOSE
HERITAGE
LATEST TOPIC
PREVIOUS EVENTS
Striving for TRANSFORMATIONAL VALUE:
Are we ready for radical change?
The Renaissance Heritage
“Adelphi Renaissance has been going for 13 years. We launched it on our 20th anniversary as a company. We wanted to plough something back into the healthcare industry that we serve, and we came up with the idea of Renaissance. So what is Renaissance?…
Renaissance provides a platform for senior decision makers to trade knowledge on hot topics. It brings together esteemed people both as speakers and panels in a meeting setting to actually air and discuss those hot topics of the day and hopefully to progress them. Over the years we have covered 7 different topics and 17 forums. On each topic we usually do one meeting in Europe and one in the United States. We involve a fairly select audience and usually we have between 20 and 40 guests in addition to the speakers. I am proud to say we always get absolutely fantastic speakers.
Please take a look at this website for the outputs from previous meetings and contact us for more information.”
Stuart Cooper, CEO, Adelphi Group
Outstanding Faculty
Each Adelphi Renaissance forum has its own unique expert faculty, who are passionate about the topic, representing a range of perspectives from academia, the medical profession, pharma industry, patients, regulatory and payer bodies.
Next Event
Striving for TRANSFORMATIONAL VALUE:
Are we ready for radical change?
March 2020 : Paris : One day thought leadership forum
“How do we translate this ground-breaking innovation into transformative value for patients, healthcare professionals and society?”
Why Attend?
- Hear the views of opinion formers representing the physician, payer, patient and pharma perspective.
- Reflect on your own company strategy through informed discussion with senior decision makers.
- Experience an environment of regulatory and commercial excellence.
- Trade knowledge in a joint effort to define best practice in critical decision and development areas.
“What steps must we as an industry take to achieve the desired transformation in healthcare?”
Previous Renaissance Topics
PATIENTCENTRICITY:
Defining our Role
2016-2017
REAL WORLD EVIDENCE:
The New Standard of Proof
2014-2015
PERSONALISED MEDICINE:
Moving from Promise to Practice
2011-2013
THE PATIENT EXPERIENCE IN CONTEXT:
Understanding its Impact on Future Pharma Strategies
2008-2010
